Progress toward developing a carbohydrate-conjugate vaccine against Clostridium difficile ribotype 027: synthesis of the cell-surface polysaccharide PS-I repeating unit.
about
Multivalent display of minimal Clostridium difficile glycan epitopes mimics antigenic properties of larger glycansThe roles of host and pathogen factors and the innate immune response in the pathogenesis of Clostridium difficile infection.Cross Reactive Material 197 glycoconjugate vaccines contain privileged conjugation sitesClostridium difficile infection: toxins and non-toxin virulence factors, and their contributions to disease establishment and host response.Carbohydrate-based Clostridium difficile vaccines.Synthetic Glycan Microarrays.Nucleophile-Directed Stereocontrol Over Glycosylations Using Geminal-Difluorinated Nucleophiles.Neoadenoloside A, a highly functionalized diterpene C-glycoside, from Isodon adenolomus.Identification of carbohydrate anomers using ion mobility-mass spectrometry.The Design of a Clostridium difficile Carbohydrate-Based Vaccine.De novo synthesis of D- and L-fucosamine containing disaccharides.Glycan arrays containing synthetic Clostridium difficile lipoteichoic acid oligomers as tools toward a carbohydrate vaccine.Total Synthesis of Five Lipoteichoic acids of Clostridium difficile.Cyanopivaloyl Ester in the Automated Solid-Phase Synthesis of Oligorhamnans.Addressing the global need to combat multidrug resistance: carbohydrates may hold the key.Potential targets for next generation anti-microbial glycoconjugate vaccines.Nucleophil-dirigierte Stereokontrolle über Glykosylierungsreaktionen durch geminal-difluorierte NucleophileSynthesis of conjugation-ready zwitterionic oligosaccharides by chemoselective thioglycoside activation
P2860
Q28834483-61C3D1D4-576C-4399-9EA6-21321CB2EC06Q34623572-3E02B740-203C-4803-889A-786DD2AAFDA4Q35913681-CAE5D843-245D-4494-94DD-E458C006091EQ36019350-AA7A843D-D53F-4715-9423-06488557C622Q38096491-E2781A0F-DE29-4DB5-921F-3C20768CC202Q38290082-33A7D6ED-51EB-436B-8295-E942FE4623FDQ38290264-696D672F-935F-4FC7-AA23-40075C0FCD19Q39323322-3D9E144A-8AB7-4D1E-A280-A54BF0497B91Q40489012-BBDF428D-7E77-4100-8E3F-E29FE01C5B5FQ40715739-6C274BCA-D574-44F0-A883-67F115E015FBQ41192160-424E58C0-3230-4094-815C-512DA0B0A5C2Q42710354-263627D0-3916-46CA-8B0E-76DA101C08BEQ46846094-597C4704-529A-4885-B0B2-B96FD8992971Q47157988-7803B0BD-1DF6-42EC-9165-0E8863AC1F99Q48723015-7436FFCA-8E44-41BE-A20A-E9075A2A78DDQ53701548-573AAAD5-CDFD-482D-B661-0F95490C5543Q57394797-A742FEEC-D246-4D2C-A26E-DDA62718FB24Q57525962-8302F0FC-6C41-4AD0-82E4-A72A276E06C6
P2860
Progress toward developing a carbohydrate-conjugate vaccine against Clostridium difficile ribotype 027: synthesis of the cell-surface polysaccharide PS-I repeating unit.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
2011年學術文章
@zh
2011年學術文章
@zh-hant
name
Progress toward developing a c ...... accharide PS-I repeating unit.
@en
Progress toward developing a c ...... accharide PS-I repeating unit.
@nl
type
label
Progress toward developing a c ...... accharide PS-I repeating unit.
@en
Progress toward developing a c ...... accharide PS-I repeating unit.
@nl
prefLabel
Progress toward developing a c ...... accharide PS-I repeating unit.
@en
Progress toward developing a c ...... accharide PS-I repeating unit.
@nl
P2093
P2860
P921
P356
P1476
Progress toward developing a c ...... accharide PS-I repeating unit.
@en
P2093
Christopher E Martin
Markus W Weishaupt
Peter H Seeberger
P2860
P304
10260-10262
P356
10.1039/C1CC13614C
P407
P577
2011-10-01T00:00:00Z